NO20053312L - Benzofuranderivat. - Google Patents
Benzofuranderivat.Info
- Publication number
- NO20053312L NO20053312L NO20053312A NO20053312A NO20053312L NO 20053312 L NO20053312 L NO 20053312L NO 20053312 A NO20053312 A NO 20053312A NO 20053312 A NO20053312 A NO 20053312A NO 20053312 L NO20053312 L NO 20053312L
- Authority
- NO
- Norway
- Prior art keywords
- optionally substituted
- compound
- alkyl
- nitrogen
- benzofuran derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45256403P | 2003-03-07 | 2003-03-07 | |
PCT/JP2004/002633 WO2004078751A1 (ja) | 2003-03-07 | 2004-03-03 | ベンゾフラン誘導体 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20053312D0 NO20053312D0 (no) | 2005-07-06 |
NO20053312L true NO20053312L (no) | 2005-10-04 |
Family
ID=32962732
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20053312A NO20053312L (no) | 2003-03-07 | 2005-07-06 | Benzofuranderivat. |
Country Status (16)
Country | Link |
---|---|
US (1) | US7314877B2 (ja) |
EP (1) | EP1602655A4 (ja) |
JP (1) | JP4528722B2 (ja) |
KR (1) | KR20050105982A (ja) |
CN (1) | CN1326852C (ja) |
AU (1) | AU2004218161B9 (ja) |
BR (1) | BRPI0407519A (ja) |
CA (1) | CA2512280A1 (ja) |
HK (1) | HK1087105A1 (ja) |
MX (1) | MXPA05009500A (ja) |
MY (1) | MY137964A (ja) |
NO (1) | NO20053312L (ja) |
NZ (1) | NZ541064A (ja) |
RU (1) | RU2328495C2 (ja) |
TW (1) | TWI281397B (ja) |
WO (1) | WO2004078751A1 (ja) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7211577B2 (en) | 2003-03-18 | 2007-05-01 | Kowa Co., Ltd. | Water-soluble phenylpyridazine derivative and medicine containing the same |
EP1604988A1 (en) * | 2004-05-18 | 2005-12-14 | Sanofi-Aventis Deutschland GmbH | Pyridazinone derivatives, methods for producing them and their use as pharmaceuticals |
DE102005057924A1 (de) * | 2005-12-05 | 2007-06-06 | Merck Patent Gmbh | Pyridazinonderivate |
EP2051728A4 (en) | 2006-03-09 | 2010-03-31 | Om Pharma | IMMUNOMODULATORY COMPOUNDS AND TREATMENT OF ILLNESSES DUE TO OVERPRODUCTION OF INFLAMMATORY CYTOKINS |
FR2941947B1 (fr) * | 2009-02-12 | 2011-03-25 | Sanofi Aventis | Derives de 3-benzofuranyl-indol-2-one subtitues en 3, leur preparation et leur application en therapeutique |
CN101845032B (zh) * | 2010-06-03 | 2011-11-30 | 广东德鑫制药有限公司 | 一种酚类化合物及用途 |
CN103003270B (zh) | 2010-07-22 | 2014-11-12 | 扶桑药品工业株式会社 | 苯并呋喃酮化合物以及含有该化合物的药物组合物 |
SG191945A1 (en) * | 2011-01-14 | 2013-08-30 | Vertex Pharma | Process of making gyrase and topoisomerase iv inhibitors |
WO2013065880A1 (ko) | 2011-10-31 | 2013-05-10 | 한국전력공사 | 건식 이산화탄소 포집 공정용 아민 또는 그 화합물을 포함하는 고체 이산화탄소 흡수제 및 그 제조방법 |
KR101652199B1 (ko) * | 2015-06-03 | 2016-08-30 | 영남대학교 산학협력단 | 신규 벤조퓨란온 유도체 화합물, 이의 제조 방법 및 이를 유효성분으로 포함하는 염증성 장질환 예방 또는 치료용 조성물 |
KR20180006522A (ko) | 2016-07-07 | 2018-01-18 | 삼성디스플레이 주식회사 | 액정 조성물 및 이를 포함하는 액정 표시 장치 |
CN108440468B (zh) * | 2018-04-17 | 2022-09-23 | 南华大学 | 2-(苯并呋喃-5-基)苯酚及其作为抗癌药物的应用 |
BR112021008905A2 (pt) | 2018-11-06 | 2021-08-10 | Edgewise Therapeutics, Inc. | compostos de piridazinona e usos dos mesmos |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3093507B2 (ja) * | 1993-02-15 | 2000-10-03 | キヤノン株式会社 | 液晶性化合物、これを含む液晶組成物、それを有する液晶素子、それらを用いた表示方法および表示装置 |
DE69718306D1 (de) | 1996-04-12 | 2003-02-13 | Sumitomo Pharma | Piperidinylpyrimidine derivate |
JP3337992B2 (ja) | 1997-11-04 | 2002-10-28 | ファイザー製薬株式会社 | 5−置換ピコリン酸化合物及びその製造方法 |
PT1043317E (pt) * | 1997-11-19 | 2009-05-11 | Kowa Co | Novos derivados de piridazina e fármacos que os contêm como ingrediente activo |
TWI241295B (en) * | 1998-03-02 | 2005-10-11 | Kowa Co | Pyridazine derivative and medicine containing the same as effect component |
JP2000247959A (ja) * | 1999-02-26 | 2000-09-12 | Kowa Co | ピリダジン−3−オン誘導体及びこれを含有する医薬 |
JP2000290261A (ja) * | 1999-04-01 | 2000-10-17 | Mitsui Chemicals Inc | ジヒドロピリダジノン誘導体およびそれを有効成分として含有する腫瘍壊死因子産生抑制剤 |
WO2001022966A1 (en) | 1999-09-30 | 2001-04-05 | Smithkline Beecham Corporation | Caspases and apoptosis |
JP4502435B2 (ja) | 1999-11-30 | 2010-07-14 | 興和創薬株式会社 | 4,5,6,7−テトラヒドロチエノ〔2,3−c〕ピリジン系化合物 |
JP4548882B2 (ja) | 1999-11-30 | 2010-09-22 | 興和創薬株式会社 | 4,5,6,7−テトラヒドロチエノ〔2,3−c〕ピリジン化合物 |
JP4548884B2 (ja) | 1999-12-03 | 2010-09-22 | 興和創薬株式会社 | 4,5,6,7−テトラヒドロチエノ〔2,3−c〕ピリジン誘導体 |
MXPA02007525A (es) | 2000-02-09 | 2002-12-13 | Hokuriku Pharmaceutical | Derivados 1h-imidazopiridina.. |
US20030139419A1 (en) | 2000-02-21 | 2003-07-24 | Bernard Barlaam | Arylpiperazines and arylpiperidines and their use as metalloproteinase inhibiting agents |
JP2003523994A (ja) | 2000-02-24 | 2003-08-12 | スミスクライン ビーチャム パブリック リミテッド カンパニー | 新規cd23インヒビター |
AU3740101A (en) | 2000-03-01 | 2001-09-12 | Janssen Pharmaceutica Nv | 2,4-disubstituted thiazolyl derivatives |
US6664256B1 (en) * | 2000-07-10 | 2003-12-16 | Kowa Co., Ltd. | Phenylpyridazine compounds and medicines containing the same |
BR0212848A (pt) * | 2001-09-26 | 2004-08-17 | Kowa Co | Derivados fenilpiridazina hidrossolúveis e medicamentos contendo os mesmos |
US6861428B2 (en) * | 2001-09-26 | 2005-03-01 | Kowa Co., Ltd. | Water-soluble phenylpyridazine compounds and compositions containing the same |
JP3774710B2 (ja) | 2003-06-27 | 2006-05-17 | 横浜ゴム株式会社 | 空気入りタイヤ |
-
2004
- 2004-03-03 RU RU2005131018/04A patent/RU2328495C2/ru not_active IP Right Cessation
- 2004-03-03 KR KR1020057012914A patent/KR20050105982A/ko not_active Application Discontinuation
- 2004-03-03 JP JP2005503069A patent/JP4528722B2/ja not_active Expired - Fee Related
- 2004-03-03 WO PCT/JP2004/002633 patent/WO2004078751A1/ja active Application Filing
- 2004-03-03 US US10/547,779 patent/US7314877B2/en not_active Expired - Fee Related
- 2004-03-03 NZ NZ541064A patent/NZ541064A/en unknown
- 2004-03-03 CN CNB2004800059391A patent/CN1326852C/zh not_active Expired - Fee Related
- 2004-03-03 AU AU2004218161A patent/AU2004218161B9/en not_active Ceased
- 2004-03-03 MX MXPA05009500A patent/MXPA05009500A/es active IP Right Grant
- 2004-03-03 BR BRPI0407519-6A patent/BRPI0407519A/pt not_active IP Right Cessation
- 2004-03-03 CA CA002512280A patent/CA2512280A1/en not_active Abandoned
- 2004-03-03 EP EP04716775A patent/EP1602655A4/en not_active Withdrawn
- 2004-03-05 TW TW093105878A patent/TWI281397B/zh not_active IP Right Cessation
- 2004-03-05 MY MYPI20040776A patent/MY137964A/en unknown
-
2005
- 2005-07-06 NO NO20053312A patent/NO20053312L/no not_active Application Discontinuation
-
2006
- 2006-06-27 HK HK06107242A patent/HK1087105A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2004078751A1 (ja) | 2004-09-16 |
NO20053312D0 (no) | 2005-07-06 |
JPWO2004078751A1 (ja) | 2006-06-08 |
RU2005131018A (ru) | 2006-02-10 |
HK1087105A1 (en) | 2006-10-06 |
AU2004218161A1 (en) | 2004-09-16 |
CN1326852C (zh) | 2007-07-18 |
EP1602655A1 (en) | 2005-12-07 |
MY137964A (en) | 2009-04-30 |
CN1756753A (zh) | 2006-04-05 |
TW200420292A (en) | 2004-10-16 |
BRPI0407519A (pt) | 2006-02-14 |
AU2004218161B2 (en) | 2009-10-29 |
US7314877B2 (en) | 2008-01-01 |
MXPA05009500A (es) | 2005-10-18 |
RU2328495C2 (ru) | 2008-07-10 |
TWI281397B (en) | 2007-05-21 |
US20060189621A1 (en) | 2006-08-24 |
JP4528722B2 (ja) | 2010-08-18 |
AU2004218161B9 (en) | 2009-11-26 |
CA2512280A1 (en) | 2004-09-16 |
EP1602655A4 (en) | 2010-06-09 |
KR20050105982A (ko) | 2005-11-08 |
NZ541064A (en) | 2007-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20053312L (no) | Benzofuranderivat. | |
ATE324371T1 (de) | N-substituierte heterocyclische nichtaryl- nmda/nr2b-antagonisten | |
NO20054852L (no) | GFAT inhibitorer | |
CY1109441T1 (el) | Ενδιαμεσα προϊοντα για την παραγωγη διοξανιου-2-αλκυλκαρβαμικου | |
NO20082561L (no) | Nye koblede pyrrolderivater | |
TW200500339A (en) | Pyrrolidine derivatives, and process for the preparation | |
MXPA02011370A (es) | Iminoazinas substituidas. | |
TW200702330A (en) | 3,4,5-Substituted piperidines | |
NO20052182L (no) | Nye forbindelser | |
DE602004009200D1 (de) | Tetrahydrochinazolinderivate als cfr-antagonisten | |
MXPA05011962A (es) | Oxiarenos substituidos. | |
MX2009006334A (es) | Derivados de heteroaril-pirrolidinil- y -piperidinil-cetona. | |
DE602004031410D1 (de) | Inden derivate als pharmazeutika | |
EA200500191A1 (ru) | Кристаллический 2,5-дион-3-(1-метил-1h-индол-3-ил)-4-[1-(пиридин-2-илметил)пиперидин-4-ил]-1h-индол-3-ил]-1h-пирролмоногидрохлорид | |
EA200600607A1 (ru) | Производные имидазопиридина в качестве ингибиторов индуцируемой no-синтазы | |
ATE488510T1 (de) | Heterocyclische derivate, deren herstellung und therapeutische verwendung | |
SI1845780T1 (sl) | Uporaba derivatov metilfenidata | |
TW200504059A (en) | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof | |
FR2894579B1 (fr) | Derives diaryltriazolmethylamine, leur preparation et leur application en therapeutique. | |
GEP20063896B (en) | New heterocyclic oxime compound, method for production of the same and pharmaceutical composition comprising the same | |
DE602006013828D1 (en) | 4-aryloxy-chinolin-derivate als 5-ht6-modulatoren | |
TW200612944A (en) | 4-(2,4-dichloro-5-methoxyphenyl)amino-6-methoxy-7-{[5-(substituted-amino)methyl]-3-furyl}-3-quinolinecarbonitriles as kinase inhibitors | |
ATE469887T1 (de) | Substituierte heterocyclische verbindungen und deren verwendung zur behandlung multipler medikamentenresistenz | |
TW200603800A (en) | 4-arylmorpholin-3-one derivatives, preparation thereof and therapeutic application thereof | |
MXPA05013732A (es) | Proceso para preparacion de sensibilizador de insulina y compuesto intermediario del mismo. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |